NCT03516110 2026-01-23
PRISME
Ipsen
Completed
Clinical Trials
34 trialsNCT07319689 2026-01-06
Predictors of Myasthenia Gravis Outcome Following Thoracoscopic Thymectomy: Comparative Study Between Thymomatous and Non-Thymomatous Patients
Tanta University
Completed
NCT05308966 2025-10-06
MESO-IMMUNE
Groupe Francais De Pneumo-Cancerologie
Completed
NCT05450367 2025-09-12
PRONOSTIM
Assistance Publique - Hôpitaux de Paris
Completed
NCT05017662 2025-09-04
A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072
Ariceum Therapeutics GmbH
Phase NA Completed
NCT05583318 2025-07-23
LymphoVie 2
Centre Hospitalier Universitaire Dijon
Completed
NCT02312960 2025-03-25
Radium-223 Dichloride Long-term Follow-up Program
Bayer
Phase 4 Completed
NCT03259230 2024-09-19
Evaluation of IFNγ and Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic Lymphohistiocytosis
Swedish Orphan Biovitrum
Completed
NCT06440044 2024-07-15
Recurrence and Bleeding in Colorectal Cancer Patients With Cancer-associated Venous Thrombembolism
Sixth Affiliated Hospital, Sun Yat-sen University
Completed
NCT04846556 2023-10-11
Cancer Associated Thrombosis : What is the Proportion of Patients Ineligible to a Study as CARAVAGGIO
Centre Hospitalier Universitaire de Saint Etienne
Completed
NCT03234335 2023-05-06
IRMYG
Centre Hospitalier Universitaire de Saint Etienne
Completed
NCT03419572 2022-08-15
CASSIOPE
Ipsen
Completed
NCT04775446 2022-02-04
MESOIMMUNE
Centre Hospitalier Intercommunal Creteil
Completed
NCT04590716 2021-07-29
Help Build an A.I. Model to Predict Myasthenia Gravis Symptom Patterns and Flares
doc.ai inc
Completed
NCT02651246 2021-06-24
Optional Sub-study to Intraoperative Imaging With ICG Registry
Abramson Cancer Center at Penn Medicine
Completed
NCT03562091 2020-08-28
OPERA
Ipsen
Completed
NCT03112694 2020-06-02
Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors
Ipsen
Completed
NCT04089995 2020-03-17
COATS+
University Hospital, Limoges
Completed
NCT03220087 2018-12-21
RECOSY
Ipsen
Completed
NCT01101542 2018-07-23
Evaluation of Safety of a Vaccine Against Cervical Cancer in Healthy Korean Females
GlaxoSmithKline
Completed
NCT02300831 2017-07-14
LUMINIST
AstraZeneca
Completed
NCT02262273 2017-03-01
OSCA
AstraZeneca
Completed
NCT01953822 2016-12-26
Study Assessing Risk of Autoimmune Diseases in Females (9 - 25 Years) Exposed to Cervarix® in United Kingdom
GlaxoSmithKline
Completed
NCT02883933 2016-08-30
head neck-mel
CHU de Reims
Completed
NCT02883946 2016-08-30
RITUX-LEUKEMIA
CHU de Reims
Completed
NCT01498627 2015-04-06
PGRx
GlaxoSmithKline
Completed
NCT01153906 2014-12-02
Post-marketing Safety Study of Autoimmune Diseases Following Cervarix® Vaccination
GlaxoSmithKline
Completed
NCT00776958 2014-07-31
Lynne Cohen Consortium Project: Multi-Center Database/Registry
M.D. Anderson Cancer Center
Completed
NCT01772225 2014-03-31
LuCaBIS
GlaxoSmithKline
Completed
NCT01905462 2013-09-30
Post-marketing Safety Study to Assess the Risk of Spontaneous Abortions in Women Exposed to Cervarix Residing in UK
GlaxoSmithKline
Completed
NCT01207999 2012-11-22
Type Distribution of Human Papillomavirus in Adult African Women Diagnosed With Invasive Cervical Cancer
GlaxoSmithKline
Completed
NCT01213459 2012-11-22
Study on the Prevalence of Human Papillomavirus Types in Women >= 15 Years of Age in the Kingdom of Saudi Arabia
GlaxoSmithKline
Completed
NCT01328028 2012-08-27
Human Papillomavirus (HPV) Type Distribution in Adult Women Diagnosed With Invasive Cervical Cancer in New Zealand
GlaxoSmithKline
Completed
NCT01221987 2012-04-30
Cross-sectional Study on Human Papillomavirus Type Distribution in Adult Women Diagnosed With Cervical Cancer
GlaxoSmithKline
Completed